Exelixis (EXEL)
NASDAQ:EXEL
Holding EXEL?
Track your performance easily

Exelixis (EXEL) Stock Investors

2,818 Followers
Based on 765,504 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

0.1% of all portfolios hold EXEL
On average, investors allocate 3.60% of their portfolios to EXEL
The average holding size of this company in investors' portfolios.

Investor Sentiment

Positive
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 765,504 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding EXEL

1.7%
Last 7
Days
5.7%
Last 30
Days
Percentages indicate the change in the number of portfolios holding EXEL, out of 765,504 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

EXEL Investor Activity

Action
Any
Any
Investor Performance
Any
Any
Investor Profile
Investor Action
Transaction Date
Portfolio Allocation
Execution Price
Follow
Opened
0.00%
$28.66
Based on the activity of 14,640 investors who made their portfolios public
The table shows changes in EXEL in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

EXEL Investors Also Bought

Investor Type
Any
Any
All Investors
Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
Bristol-Myers Squibb
3.55%
-0.10%
-2.40%
112.46B
Healthcare
Block
4.28%
-0.06%
+1.28%
44.75B
Technology
DraftKings
5.34%
+0.89%
-0.84%
31.36B
Consumer Cyclical
Enphase Energy
4.82%
-0.18%
+3.36%
11.82B
Technology
Plug Power
5.29%
+0.15%
+0.20%
2.21B
Industrials
Merck & Company
3.52%
+0.35%
+5.89%
258.22B
Healthcare
Cisco Systems
4.39%
-0.69%
+0.02%
222.54B
Technology
Abbott Laboratories
3.63%
+1.10%
+14.68%
204.06B
Healthcare
Citigroup
4.72%
+1.71%
+3.52%
117.92B
Financial
Trade Desk
4.92%
-0.72%
+1.69%
58.30B
Technology
Based on the activity of 765,504 active portfolios
Open your Smart Portfolio

EXEL Investor Analysis

EXEL investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
12.1%
of EXEL holders
are under 35
Average Segment Performance
Average P/E Ratio23.45
Beta10.33
Dividend Yield51.46%
EXEL investors between 35–55

Between 35–55

3.2%
Last 30 days
Holdings Change
50.2%
of EXEL holders
are between 35–55
Average Segment Performance
Average P/E Ratio21.88
Beta20.26
Dividend Yield24.92%
EXEL investors over 55

Over 55

9.0%
Last 30 days
Holdings Change
37.8%
of EXEL holders
are over 55
Average Segment Performance
Average P/E Ratio21.22
Beta8.93
Dividend Yield41.53%
Overview of age group and performance of EXEL stock investors
See who invests in EXEL according to age group and performance.

FAQ

How many retail Investors hold EXEL?
0.1% of TipRanks' retail investors hold EXEL in their portfolios.
    What is EXEL Investor Sentiment?
    EXEL’s Investor Sentiment is Positive.
      What percentage of retail investors changed their holding of EXEL in the last 7 days?
      ▼ 1.7% of TipRanks' retail investors changed their holding of EXEL in the last 7 days.
        What percentage of retail investors changed their holding of EXEL in the last 30 days?
        ▲ 5.7% of TipRanks' retail investors changed their holding of EXEL in the last 30 days.
          What is the average age of retail investors who hold EXEL?
          The average age of EXEL Holders is between 35–55.
            What other stocks have EXEL investors also bought?
            EXEL Investors also bought BMY, SQ, DKNG, ENPH, PLUG, MRK, CSCO, ABT, C, TTD.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              ABTAbbott Laboratories
              AGENAgenus
              AAgilent
              BDXBecton Dickinson
              BIIBBiogen
              What am I Missing?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis